J70.4
Drug-induced interstitial lung disorders, unspecified
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Excludes Type 1
- interstitial pneumonia NOS (J84.9)
- lymphoid interstitial pneumonia (J84.2)
Medical Intelligence & Overview
Drug-induced interstitial lung disorders are a group of lung conditions caused by adverse reactions to certain medications. These disorders involve inflammation and scarring of the tissue surrounding the lung's air sacs, which can impair breathing and oxygen transfer. The specific ICD-10 code J70.4 refers to cases where these lung problems are caused by drugs, but the exact nature of the disorder isn't specified. Recognizing and managing these conditions promptly is essential to prevent serious lung damage.
Causes & Symptoms
Clinical Causes: Use of certain medications such as chemotherapy drugs, antibiotics, anti-inflammatory drugs, and heart medications Prolonged or high-dose therapy with substances that can affect lung tissue Reactions to new medications or changes in existing drug regimens Concurrent exposure to other lung irritants, such as smoking or environmental toxins, which can compound the effects
Key Symptoms: Persistent dry cough Shortness of breath or difficulty breathing, especially during exertion Fatigue and weakness Chest discomfort or pain Fever and malaise in some cases Unexplained weight loss in chronic cases
Diagnostic & Treatment
Diagnosis Path: Medical history review to examine recent medication use Physical examination to detect abnormal lung sounds Imaging tests such as high-resolution CT scans to visualize lung tissue and detect patterns of inflammation or scarring Pulmonary function tests to assess lung capacity and airflow Laboratory tests to exclude other causes of lung symptoms In some cases, lung biopsy may be performed to confirm diagnosis
Treatment Protocols: Discontinuing or adjusting the suspected offending medication under medical supervision Use of corticosteroids or other anti-inflammatory medications to reduce lung inflammation Supportive care, including oxygen therapy if necessary Monitoring lung function over time to assess response to treatment Addressing complications such as infections or respiratory failure Rehabilitation programs to improve breathing capacity and overall strength
Clinical Advice & FAQs
Billing Guidance
Is J70.4 a billable ICD-10 code?
Yes, J70.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J70.4?
Clinical documentation must specify the nature of Drug-induced interstitial lung disorders, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference